Understanding RTN4R: Potential Drug Target and Biomarker (G65078)
Understanding RTN4R: Potential Drug Target and Biomarker
RTN4R, also known as neurotactin-4 receptor, is a G protein-coupled receptor that is expressed in various tissues of the body, including the brain, lungs, heart, and kidneys. This receptor is involved in various physiological processes in the body, including blood pressure, heart rate, and blood vessel diameter. Despite its importance, little is known about this receptor, and it has not been thoroughly studied.
In recent years, the discovery of new drug targets has become an exciting development in the field of pharmacology. These targets are molecules that are responsible for specific physiological processes and are targeted by drugs to modulate their activity. The RTN4R is a potential drug target because of its involvement in various physiological processes and its potential role in the development of certain diseases.
Diseases associated with RTN4R
RTN4R has been implicated in the development and progression of several diseases, including heart failure, hypertension, and chronic kidney disease. These conditions are characterized by the failure of the heart to pump blood efficiently, leading to decreased blood pressure and an increase in the risk of cardiovascular events.
In addition to its involvement in heart failure and hypertension, RTN4R has also been linked to the development of chronic kidney disease. Chronic kidney disease is a condition in which the kidneys gradually lose their function over time, leading to a decline in kidney function. Studies have shown that RTN4R is expressed in the kidneys and that its activation can contribute to the development and progression of chronic kidney disease.
RTN4R as a drug target
The potential use of RTN4R as a drug target is based on its involvement in various physiological processes and its potential role in the development of diseases. Because of its involvement in these processes, RTN4R has potential as a therapeutic target for a variety of conditions.
One potential approach to targeting RTN4R is to use small molecules that can modulate its activity. These small molecules can be designed to interact with RTN4R and either activate or inhibit its signaling. This approach has been used to develop new treatments for a variety of conditions, including heart failure and hypertension.
Another potential approach to targeting RTN4R is to use antibodies that recognize and target specific regions of the receptor. This approach has been used to develop new treatments for a variety of conditions, including cancer and autoimmune diseases.
RTN4R as a biomarker
In addition to its potential as a drug target, RTN4R may also be used as a biomarker for the diagnosis and monitoring of certain conditions. For example, because RTN4R is involved in heart rate and blood vessel diameter, it may be used as a biomarker for the assessment of cardiovascular health.
In addition, RTN4R may be used as a biomarker for the diagnosis and monitoring of chronic kidney disease. As mentioned earlier, RTN4R is involved in the development and progression of chronic kidney disease, and its activation has been linked to the development of this condition. Therefore, measuring the level of RTN4R in the kidneys may be a useful diagnostic tool for the assessment of chronic kidney disease.
Conclusion
RTN4R is a G protein-coupled receptor that is involved in various physiological processes in the body. Despite its importance, little is known about this receptor, and it has not been thoroughly studied. The potential use of RTN4R as a drug target and biomarker makes it an exciting area of research, and further studies are needed to fully understand its role in the development and progression of various diseases.
Protein Name: Reticulon 4 Receptor
Functions: Receptor for RTN4, OMG and MAG (PubMed:12037567, PubMed:12068310, PubMed:12426574, PubMed:12089450, PubMed:16712417, PubMed:18411262, PubMed:12839991, PubMed:19052207). Functions as receptor for the sialylated gangliosides GT1b and GM1 (PubMed:18411262). Besides, functions as receptor for chondroitin sulfate proteoglycans (By similarity). Can also bind heparin (By similarity). Intracellular signaling cascades are triggered via the coreceptor NGFR (PubMed:12426574). Signaling mediates activation of Rho and downstream reorganization of the actin cytoskeleton (PubMed:16712417, PubMed:22325200). Mediates axonal growth inhibition (PubMed:12839991, PubMed:19052207, PubMed:28892071). Plays a role in regulating axon regeneration and neuronal plasticity in the adult central nervous system. Plays a role in postnatal brain development. Required for normal axon migration across the brain midline and normal formation of the corpus callosum. Protects motoneurons against apoptosis; protection against apoptosis is probably mediated via interaction with MAG. Acts in conjunction with RTN4 and LINGO1 in regulating neuronal precursor cell motility during cortical development. Like other family members, plays a role in restricting the number dendritic spines and the number of synapses that are formed during brain development (PubMed:22325200)
The "RTN4R Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RTN4R comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3 | S100A4 | S100A5 | S100A6 | S100A7 | S100A7A | S100A7L2 | S100A7P1 | S100A8 | S100A9 | S100B | S100G | S100P | S100PBP | S100Z | S1PR1 | S1PR1-DT | S1PR2 | S1PR3 | S1PR4 | S1PR5 | SAA1 | SAA2 | SAA2-SAA4 | SAA3P | SAA4 | SAAL1 | SAC3D1 | SACM1L | SACS | SACS-AS1 | SAE1 | SAFB | SAFB2 | SAG | SAGA complex
